[Skip to Navigation]
Views 174
Citations 0
Editor's Correspondence
Oct 22, 2012

What Is More Valuable: Fenofibrate Patents or Fenofibrate Clinical Outcomes?

Author Affiliations

Author Affiliation: Department of Pharmaceutical Economics and Policy, University of Southern California, Los Angeles.

Arch Intern Med. 2012;172(19):1521-1522. doi:10.1001/archinternmed.2012.4386
Add or change institution
×